Replies to post #16805 on Momenta Pharmaceuticals, Inc. (MNTA)

[alternatepatel]

2017 approval hope is still alive

" With the potential for the approval and launch of Glatopa 40 mg and with multiple data readouts expected across our biosimilar and novel programs this year, we believe 2017 could be a transformative year for Momenta."